These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 19357135

  • 1. Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial.
    Urman B, Ata B, Yakin K, Alatas C, Aksoy S, Mercan R, Balaban B.
    Hum Reprod; 2009 Jul; 24(7):1640-7. PubMed ID: 19357135
    [Abstract] [Full Text] [Related]

  • 2. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J, Cholquevilque JL, Cela V, Martínez-Salazar J, Requena A, Garcia-Velasco JA.
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [Abstract] [Full Text] [Related]

  • 3. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study.
    Ata B, Yakin K, Balaban B, Urman B.
    Hum Reprod; 2008 Mar; 23(3):668-73. PubMed ID: 18192671
    [Abstract] [Full Text] [Related]

  • 4. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P, Chun Cheung M, Ping Cheung L, Ingrid Lok H, John Haines C.
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
    Drakakis P, Loutradis D, Vomvolaki E, Stefanidis K, Kiapekou E, Anagnostou E, Anastasiadou K, Milingos S, Antsaklis A.
    Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial.
    Ghanem ME, Sadek EE, Elboghdady LA, Helal AS, Gamal A, Eldiasty A, Bakre NI, Houssen M.
    Fertil Steril; 2009 Aug; 92(2):486-93. PubMed ID: 19464001
    [Abstract] [Full Text] [Related]

  • 9. Day 4 versus day 3 embryo transfer: a prospective study of clinical outcomes.
    Pantos K, Makrakis E, Chronopoulou M, Biba M, Perdikaris A, Dafereras A.
    Fertil Steril; 2008 Mar; 89(3):573-7. PubMed ID: 17517409
    [Abstract] [Full Text] [Related]

  • 10. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C, Donnez J, Loumaye E.
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [Abstract] [Full Text] [Related]

  • 11. Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.
    Chen H, Wang Y, Lyu Q, Ai A, Fu Y, Tian H, Cai R, Hong Q, Chen Q, Shoham Z, Kuang Y.
    Fertil Steril; 2015 May; 103(5):1194-1201.e2. PubMed ID: 25813280
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Extension of GnRH agonist through the luteal phase to improve the outcome of intracytoplasmic sperm injection.
    Isikoglu M, Ozgur K, Oehninger S.
    J Reprod Med; 2007 Jul; 52(7):639-44. PubMed ID: 17847764
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.
    Bergh C, Lindenberg S, Nordic Crinone Study Group.
    Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296
    [Abstract] [Full Text] [Related]

  • 16. Greater implantation and pregnancy rates with vaginal progesterone in intracytoplasmic sperm injection but not in in vitro fertilization cycles: a retrospective study.
    Manno M, Marchesan E, Cicutto D, Zadro D, Favretti C, Tomei F.
    Fertil Steril; 2005 May; 83(5):1391-6. PubMed ID: 15866574
    [Abstract] [Full Text] [Related]

  • 17. Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles.
    Gorkemli H, Ak D, Akyurek C, Aktan M, Duman S.
    Gynecol Obstet Invest; 2004 May; 58(3):140-4. PubMed ID: 15205566
    [Abstract] [Full Text] [Related]

  • 18. Beneficial effect of luteal-phase gonadotropin-releasing hormone agonist administration on implantation rate after intracytoplasmic sperm injection.
    Razieh DF, Maryam AR, Nasim T.
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):245-8. PubMed ID: 19797013
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.